Exosomal miR-6126 as a novel therapeutic target for overcoming resistance of anti-cancer effect in hepatocellular carcinoma
Exosomal miR-6126 plays a pivotal role in sorafenib resistance and tumorigenesis, highlighting its potential as a novel therapeutic target for overcoming drug resistance in HCC.
Authors
- Hyemin Hwang
- Sua Cho
- Won Jong Rhee (ORCID: https://orcid.org/0000-0001-7068-2762)
- Jae‐Chul Pyun (ORCID: https://orcid.org/0000-0001-9954-6860)
- Yeonju Han
- Misu Lee (ORCID: https://orcid.org/0000-0001-9208-2127)
- Filippo Piccinini (ORCID: https://orcid.org/0000-0002-0371-7782)
- Tae‐Hun Kim (ORCID: https://orcid.org/0000-0002-8448-3219)
- Seung Hwan Kim (ORCID: https://orcid.org/0000-0002-5898-6517)
- Sanghee Park (ORCID: https://orcid.org/0000-0003-0532-906X)
- Tae-Hyun Park
- Dong Wook Choi (ORCID: https://orcid.org/0000-0002-0751-7841)
- Ji Min Kim (ORCID: https://orcid.org/0000-0002-9819-0775)
Institutions
- Incheon National University (KR)
- Yonsei University (KR)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Bologna (IT)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1186/s12885-024-13342-y
- Citations
- 4
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Research Foundation
- Incheon National University
- National Research Foundation of Korea